# Hepatic Encephalopathy

## Length of Authorizations

365 Days

## Prior Authorization Criteria

Is there any reason the patient cannot be changed to a medication not requiring prior approval? Acceptable reasons include:

-   Allergy to medication not requiring prior approval
-   Contraindication to or drug interaction with medication not requiring prior approval
-   History of unacceptable/toxic side effects to medication not requiring prior approval

## Additional Criteria

### Step Therapy

Step Therapy Approval Critera

All agents listed

1.  For a drug requiring step therapy, there must have been inadequate clinical response to a preferred alternative
2.  XIFAXAN requires a diagnosis of hepatic encephalopathy and may be approved for monotherapy or add on therapy if there has been a therapeutic failure (defined as a recurrent episode) while on lactulose

## Formulary

Gastrointestinal Agents: Hepatic Encephalopathy

### Preferred

| Preferred  |      |
| :--------- | ---: |
| Lactulose  |      |
| Xifaxan ST |      |

### Non-Preferred

| Non-Preferred |      |
| :------------ | ---: |
|               |      |

## Links

[Criteria]https://pharmacy.medicaid.ohio.gov/sites/default/files/20221001_UPDL_Criteria_APPROVED.pdf#page=62)

[Preferred Drug List](https://pharmacy.medicaid.ohio.gov/sites/default/files/20221001_UPDL_APPROVED_.pdf#page=23)
